Mucinous cystic neoplasm (MCN) is a premalignant cystic tumor of the pancreas, comprising 10-45% of all pancreatic cystic neoplasms. Occurs almost exclusively in women (>95%) with a mean age at diagnosis of 40-50. Shows a marked predilection for the pancreatic body and tail (95%). Histologically lined by mucin-secreting columnar epithelium and contains pathognomonic ovarian-type stroma — this stroma resembles ovarian stroma found only in women and explains the female exclusivity of MCN. No communication with the pancreatic duct — the key feature distinguishing from IPMN. The dysplasia spectrum ranges from low-grade dysplasia to invasive carcinoma; surgical resection is curative and invasive component is found in 15-25% of cases.
Age Range
30-50
Peak Age
40
Gender
Female predominant
Prevalence
Uncommon
The cell of origin of MCN is debated, but the ovarian-type stromal component points to a neoplasm developing under hormonal influences. The body/tail predilection is explained by the hypothesis of misplacement of gonadal cells into the pancreatic dorsum during embryological development. Mucin-secreting epithelium creates the macrocystic architecture — large, few cysts filled with mucinous content. Mucin is a high-viscosity glycoprotein structure showing slightly higher density than fluid on CT (~15-30 HU) and mildly hyperintense signal on T1 MRI. Premalignant potential is explained by the adenoma-carcinoma sequence: low-grade dysplasia → intermediate-grade → high-grade dysplasia → invasive carcinoma. As dysplasia grade increases, cyst wall thickening, mural nodule development, and solid component increase are observed — these imaging findings reflect increasing malignancy risk. Peripheral eggshell calcification indicates the chronic nature of MCN; paradoxically, peripheral calcification presence has also been associated with malignancy risk.
Thin curvilinear calcification in the peripheral portion of the cystic mass — eggshell pattern. This peripheral calcification is characteristic for MCN and distinguishes from the central sunburst calcification of serous cystadenoma. Found in 10-25% of cases.
Well-defined, round/oval, unilocular or paucilocular (few large cysts) macrocystic mass in the pancreatic body or tail. Cyst size usually ranges from 2-20 cm. Cyst content is mucinous and may show slightly higher density than fluid (~15-30 HU). Cyst wall is conspicuous and shows post-contrast enhancement. Thick septa (>2 mm) and enhancing mural nodules are findings favoring malignancy.
Report Sentence
A well-defined macrocystic mass in the pancreatic body/tail is identified, consistent with mucinous cystic neoplasm; presence of mural nodules and thick septa should be evaluated for malignancy.
Thin curvilinear (eggshell) calcification along the cyst periphery. Unlike the central calcification of serous cystadenoma, calcification in MCN shows peripheral localization. Seen in 10-25% of cases. Peripheral calcification has paradoxically been associated with malignancy risk.
Report Sentence
Eggshell pattern calcification in the peripheral portion of the cystic mass is identified, consistent with mucinous cystic neoplasm.
Several large cysts with high signal separated by thick septa and cyst wall with low signal on T2-weighted images. Mucinous cyst content shows high signal on T2 but may be slightly lower than simple fluid depending on protein content. MRCP sequences demonstrate lack of cyst-duct communication (MCN has no connection with main pancreatic duct). Mural nodules show intermediate signal on T2.
Report Sentence
A macrocystic mass with high signal in the pancreatic body/tail on T2-weighted images is identified, with no pancreatic duct communication demonstrated on MRCP.
Cyst content may show mildly hyperintense signal compared to simple fluid on T1-weighted images due to mucinous composition. If protein/mucin concentration is high, T1 signal may notably increase. This feature helps distinguish from simple cyst. T1 signal may further increase in the presence of hemorrhage. Post-contrast T1 shows enhancement of cyst wall and septa; mural nodules enhance prominently.
Report Sentence
Cyst content shows mildly higher signal than simple fluid on T1-weighted images, consistent with mucinous content.
Well-defined, thick-walled macrocystic mass in the pancreatic body/tail. Internal echoes may be mildly increased depending on the viscosity of mucinous cyst fluid. Thick septa are seen as hyperechoic bands. Mural nodules are seen as solid hypoechoic protrusions and may show vascularity on Doppler. US is the first step in diagnosis and characterization with CT/MR is required.
Report Sentence
A thick-walled macrocystic mass in the pancreatic body/tail is identified; further characterization (CT/MR) is recommended.
Criteria
Minimal epithelial atypia, thin wall (<2 mm), regular septa, no mural nodules.
Distinct Features
Smooth, thin-walled macrocystic mass on imaging. No invasion findings. Post-surgical prognosis is excellent (near 100% 5-year survival).
Criteria
Marked epithelial atypia, thick/irregular wall (>2 mm), enhancing mural nodules, solid component. In invasive carcinoma, wall destruction and invasion into surrounding tissues.
Distinct Features
Enhancing mural nodule is the most important indicator of malignancy. Accompanied by thick wall, irregular septa, and increased solid component. In invasive carcinoma, peripancreatic fat infiltration and lymphadenopathy may be seen. 5-year survival drops to 50-60% in invasive form.
Criteria
Single or very few (1-3) large cysts. Minimal or absent septa. Smooth cyst wall.
Distinct Features
May be confused with simple cyst and pseudocyst. Pancreatic body/tail location and female gender support MCN. EUS-FNA cyst fluid analysis is mandatory for differential diagnosis (CEA >192 ng/mL, mucin positive).
Distinguishing Feature
Serous cystadenoma is microcystic (numerous small cysts <2 cm, honeycomb pattern, central sunburst calcification) while MCN is macrocystic (few large cysts, peripheral eggshell calcification). Serous in older women (>60), MCN in young-middle aged women (40-50). Serous is benign, MCN is premalignant. Serous cyst fluid: low CEA; MCN: high CEA.
Distinguishing Feature
Branch-duct IPMN shows communication with the pancreatic duct (duct-cyst communication on MRCP), while MCN lacks this connection. IPMN occurs in both genders while MCN is almost exclusively in women. IPMN has a head/uncinate process predilection while MCN is body/tail. IPMN may be multifocal while MCN is usually solitary.
Distinguishing Feature
Pseudocyst has a history of pancreatitis, peripancreatic inflammatory changes accompany, and no inner epithelium (granulation tissue wall). MCN has no pancreatitis history, ovarian-type stroma is pathognomonic, and is lined by mucin-secreting epithelium. Cyst fluid: pseudocyst has low CEA, high amylase; MCN has high CEA, low amylase.
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
specialist-referralMCN carries surgical resection indication due to premalignant potential — surgery is recommended for all MCNs (especially in young/middle-aged patients). Pancreatic body/tail location is treated with distal pancreatectomy ± splenectomy. Suspicion of malignancy increases with mural nodules, thick septa, or solid component and urgent surgery is planned. Prognosis after surgery for non-invasive MCN is excellent (near 100% cure). If invasive component is found, prognosis approaches PDAC but is still better. EUS-FNA cyst fluid analysis (CEA >192 ng/mL, mucin, cytology) is used for differential diagnosis. Surveillance may be considered in elderly/comorbid patients unfit for surgery.
MCN is a pre-malignant lesion and surgical resection is recommended. Malignancy risk has been reported between 6-36%. Mural nodule, size >4cm, thick wall, and calcification increase malignancy risk. Distal pancreatectomy is curative and prognosis after complete resection is excellent.